Clinical Trial: A Study to Assess IG001643 in Healthy Participants

U.S., Nov. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07924397) titled 'A Study to Assess IG001643 in Healthy Participants' on Oct. 27.

Brief Summary: The purpose of this study is to evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of IG001643 in Healthy Participants

Study Start Date: Nov. 10

Study Type: INTERVENTIONAL

Condition: Pain Management

Intervention: DRUG: IG001643

IG001643 oral dosage forms

DRUG: Placebo

Placebo for oral dosage forms

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Iongen Therapeutics Co., Ltd.

Published by HT Digital Content Services with permission from Health Daily Digest....